Research on Japan's innovative drug R&D incentive policy and its enlightenment to China——an empirical study based on Takeda Pharmaceutical CompanyYAN Jian-zhou, ZHU Jia-wen, CHEN Yan-yun, LIU Jia-yuan1153-1159
Research on the problems of real-world data and the measures to improve real-world data's qualityLI Wan-ting, QIAO Jia-hui, MENG Ling-quan, LIAN Gui-yu, HUANG Zhe, CHEN Yu-wen1160-1163
Analysis and discussion of generic drug consistency evaluation in NMPA and relevant drug policies in FDA and PMDALI Dong, DU Hong-jin, ZHOU Yu, LIU Dong, LIU Yi-lin, HA Li-li, LI Fang, YANG Jin-bo1164-1167
The hepatocarcinogenic effects of aristolochic acid I and associated mechanisms in C3 H/HeN suckling miceWANG Ting, WU Wen-xiao, LIN Zhi, WANG Chao, YANG Yan-wei, MIAO Yu-fa, GENG Xing-chao, LI Bo1168-1175
Intestinal permeability of conjugated estrogen using in vivo and in vitro modelsLIU Xiao-hang, ZHANG Liang, LI Xin-rong, SHAN Yu, GAO Xiao-li1176-1183
Advances in the preparation technology of sustained-release microspheres of glucagon-like peptide-1 ( GLP-1 )LIU Bo, RUAN Si-da, CAI Ting1184-1191
The current research status and progress in universal chimeric antigen receptor T-cell immunotherapyZHU Fang-ming, CAI Xiao-qing, CUI Chang, GUO Hong-xi, LU Ting-ting, XU Dao-jun1192-1199
Advances of clinical application of PARP inhibitors in ovarian cancer from pharmaceutical perspectivesWANG Yan-ting, DAI Yuan-yuan, SUN Yang-chun, LI Guo-hui1200-1206
The research progress on new formulations of andrographolideXU Du-juan, LIU Meng-ya, LIU Gai-zhi, CAI Bang-rong1207-1212
Research progress of calamus and prediction analysis of quality markersYANG He-nian, WU Su-hui, LI Han-bing, LI Gen-lin1213-1219